Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV-101 biomarkers in healthy veterans
NCT03583554Phase 2Completed
- Start
- Sep 2018
- Primary completion
- Oct 2019
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 4-chlorokynurenine in suicidal ideation. Started Sep 2018; status: completed.
02
Drugs
4-chlorokynurenine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT03583554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03583554.